Literature DB >> 30965106

Reply.

Ashwin N Ananthakrishnan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30965106      PMCID： PMC6661181          DOI： 10.1016/j.cgh.2019.04.007

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  4 in total

1.  Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis.

Authors:  Cong Dai; Min Jiang; Yu-Hong Huang
Journal:  Clin Gastroenterol Hepatol       Date:  2019-03-27       Impact factor: 11.382

2.  Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.

Authors:  Niharika Nalagatla; Katherine Falloon; Gloria Tran; Nienke Z Borren; Danny Avalos; Jay Luther; Francis Colizzo; John Garber; Hamed Khalili; Joanna Melia; Matthew Bohm; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-23       Impact factor: 11.382

3.  An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis.

Authors:  David J Gibson; Zaid S Heetun; Ciaran E Redmond; Kavin S Nanda; Denise Keegan; Kathryn Byrne; Hugh E Mulcahy; Garret Cullen; Glen A Doherty
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-30       Impact factor: 11.382

4.  Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.

Authors:  Shailja C Shah; Steven Naymagon; Hinaben J Panchal; Bruce E Sands; Benjamin L Cohen; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2018-02-15       Impact factor: 5.325
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.